Issue 2/2013
Content (14 Articles)
Integrase Strand Transfer Inhibitors in HIV Therapy
Thibault Mesplède, Mark A. Wainberg
Ceftaroline Fosamil: A Brief Clinical Review
Debbie-Ann T. Shirley, Emily L. Heil, J. Kristie Johnson
Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors
Bavithra Nathan, Jake Bayley, Laura Waters, Frank A. Post
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
Gregory J. Fox, Dick Menzies
Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine
Ruth Chin, Joseph Torresi
The Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients
Daniel Dalcin, Marina Ulanova
Is Community-Acquired Methicillin-Resistant Staphylococcus aureus Coverage Needed for Cellulitis?
Michael Horseman, John D. Bowman
Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
Molly E. Steed, Ashley D. Hall, Hossein Salimnia, Glenn W. Kaatz, Keith S. Kaye, Michael J. Rybak
Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin
Joseph J. Carreno, Anthony Jaworski, Rachel M. Kenney, Susan L. Davis
Stable Susceptibility to Aminoglycosides in an Age of Low Level, Institutional Use
John A. Bosso, Martha L. Haines, Juanmanuel Gomez
Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis
Simon W. Lam, Seth R. Bauer
Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial
Alfred B. Tiono, Amidou Diarra, Souleymane Sanon, Issa Nébié, Amadou T. Konaté, Franco Pagnoni, Sodiomon B. Sirima